Despite Significant Efforts, Today's Cardiovascular Care Faces Critical Challenges.


Introducing SP1
The world’s first wire-free, non-magnetic intravascular robot.
Unlike catheters or tethered systems, our platform is:
-
Reaches vascular regions traditional tools cannot access.
-
Enables next-generation diagnostics and therapy with wire-free, AI-guided precision.
Each robot is engineered from fully biocompatible, non-magnetic materials, measuring just 1mm in diameter and 5mm in length.
Controlled by an external infrared beacon system, with fail-safe positioning in case of signal loss.

How it Works
ARTIFICIAL MICRO-MUSCLES
SP1 is powered by biomimetic artificial micro-muscles, enabling precise locomotion and active tasks without external mechanical components or magnetic fields.
Spike’s micro-robots operate in four seamless stages:
INSERTION
Minimally invasive insertion and retrieval via a single standard catheter with a capture tool.
NAVIGATION
Autonomous movement using biomimetic propulsion. SP1 gently grips vessel walls to steer and adapt in real time.
PROCEDURE
Sensors and cameras enable AI to detect abnormalities and guide targeted drug delivery, implants, or microsurgery.
AI MONITORING
An external Infrared beacon powers and controls SP1. Real-time data enables navigation and digital twin creation. Anchors safely on signal loss.

CLINICAL APPLICATIONS
Spike Dynamics Unique Design and IP
Built on a Proven Foundation:
-
Excellent technology review from NASA.
-
“Best Hardware Startup” in SF 2023
-
Recognition/acceptance by Autodesk Innovation Center.
-
Solid IP portfolio: 3 patents granted, 10 pending
-
Strategic partnership with Northwestern University.
-
Working prototype.









Our Mission
To build AI-powered cardiovascular micro-robots that can navigate, diagnose, treat, and deliver therapy from within safely, precisely, and earlier than ever before.
We aim to give people longer, healthier lives by shifting medicine from reactive crisis response to proactive, personalized intervention.
We believe the future of heart care should be gentle, intelligent, and invisible, felt only in how much better life becomes.
Help Bring SP1 to Life.
We’re inviting bold investors, visionary clinicians, and strategic partners to help us ensure this technology can one day reach patients.

